| Colleen Ryan, MS | |
|
600 N Wolfe St, Baltimore, MD 21287-0005 | |
| (410) 955-6153 | |
| Not Available |
| Full Name | Colleen Ryan |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 27 Years |
| Location | 600 N Wolfe St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285665026 | NPI | - | NPPES |
| 795538300 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 00892 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
A new Northwestern Medicine study has found an adolescent male's attitude toward risky sex, pregnancy and birth control can predict whether or not he will end up living with his future offspring.
Federal health insurance rules are a moving target, and it's unclear whether Republicans will take another run at replacing the Affordable Care Act. In the meantime, some states are staking out strong positions on coverage of abortion, cementing their position regardless of how the federal landscape changes.
Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.
Fertility procedures such as in vitro fertilization (IVF) require a couple and the doctor to place the risky bet that the multiple eggs they choose to fertilize will produce an embryo that will thrive in the uterus. Researchers cannot biopsy eggs directly because that would destroy them, but a new discovery by professors at Brown University and Women & Infants Hospital could lead to new insights about how eggs develop and ultimately inform judgments about how the embryos they produce will fare. The idea is to examine the genetic material the egg cells discarded when they were first forming, to see which genes they were expressing.
The U.S. Food and Drug Administration has announced manufacturers of certain drugs approved to treat Type 2 diabetes have agreed to add a stronger warning on the risk of heart failure, a condition that occurs when the heart does not adequately pump blood.
› Verified 9 days ago
| Provider Name | Johns Hopkins University |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
A new Northwestern Medicine study has found an adolescent male's attitude toward risky sex, pregnancy and birth control can predict whether or not he will end up living with his future offspring.
Federal health insurance rules are a moving target, and it's unclear whether Republicans will take another run at replacing the Affordable Care Act. In the meantime, some states are staking out strong positions on coverage of abortion, cementing their position regardless of how the federal landscape changes.
Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.
Fertility procedures such as in vitro fertilization (IVF) require a couple and the doctor to place the risky bet that the multiple eggs they choose to fertilize will produce an embryo that will thrive in the uterus. Researchers cannot biopsy eggs directly because that would destroy them, but a new discovery by professors at Brown University and Women & Infants Hospital could lead to new insights about how eggs develop and ultimately inform judgments about how the embryos they produce will fare. The idea is to examine the genetic material the egg cells discarded when they were first forming, to see which genes they were expressing.
The U.S. Food and Drug Administration has announced manufacturers of certain drugs approved to treat Type 2 diabetes have agreed to add a stronger warning on the risk of heart failure, a condition that occurs when the heart does not adequately pump blood.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Colleen Ryan, MS 6201 Greenleigh Ave, Middle River, MD 21220-2004 Ph: (410) 933-6421 | Colleen Ryan, MS 600 N Wolfe St, Baltimore, MD 21287-0005 Ph: (410) 955-6153 |
News Archive
A new Northwestern Medicine study has found an adolescent male's attitude toward risky sex, pregnancy and birth control can predict whether or not he will end up living with his future offspring.
Federal health insurance rules are a moving target, and it's unclear whether Republicans will take another run at replacing the Affordable Care Act. In the meantime, some states are staking out strong positions on coverage of abortion, cementing their position regardless of how the federal landscape changes.
Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.
Fertility procedures such as in vitro fertilization (IVF) require a couple and the doctor to place the risky bet that the multiple eggs they choose to fertilize will produce an embryo that will thrive in the uterus. Researchers cannot biopsy eggs directly because that would destroy them, but a new discovery by professors at Brown University and Women & Infants Hospital could lead to new insights about how eggs develop and ultimately inform judgments about how the embryos they produce will fare. The idea is to examine the genetic material the egg cells discarded when they were first forming, to see which genes they were expressing.
The U.S. Food and Drug Administration has announced manufacturers of certain drugs approved to treat Type 2 diabetes have agreed to add a stronger warning on the risk of heart failure, a condition that occurs when the heart does not adequately pump blood.
› Verified 9 days ago
Ms. Terese D Beauchamp, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7658a Belair Rd, Baltimore, MD 21236 Phone: 410-668-9198 | |
Shannon Hahn, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 200 E 33rd St, Baltimore, MD 21218 Phone: 410-554-4455 | |
Total Audiology Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 733 W 40th St Ste 20, Baltimore, MD 21211 Phone: 410-877-0795 Fax: 877-766-8925 | |
Estelle Skinner, MS, CCC/A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2500 E Northern Pkwy, Baltimore, MD 21214 Phone: 410-515-6548 | |
Devra Brace, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 6565 N Charles St Ste 601, Baltimore, MD 21204 Phone: 410-821-5151 Fax: 410-823-8309 | |
Ms. Cynthia Ann Fannon, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6565 N Charles St, Suite 601, Baltimore, MD 21204 Phone: 410-821-5151 | |
Erin Mcdermott, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Gough St, Baltimore, MD 21224 Phone: 131-572-0456 |